Literature DB >> 23526463

Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism.

Barbara Campolina Silva1, Stephanie Boutroy, Chiyuan Zhang, Donald Jay McMahon, Bin Zhou, Ji Wang, Julia Udesky, Serge Cremers, Marta Sarquis, Xiang-Dong Edward Guo, Didier Hans, John Paul Bilezikian.   

Abstract

CONTEXT: In the milder form of primary hyperparathyroidism (PHPT), cancellous bone, represented by areal bone mineral density at the lumbar spine by dual-energy x-ray absorptiometry (DXA), is preserved. This finding is in contrast to high-resolution peripheral quantitative computed tomography (HRpQCT) results of abnormal trabecular microstructure and epidemiological evidence for increased overall fracture risk in PHPT. Because DXA does not directly measure trabecular bone and HRpQCT is not widely available, we used trabecular bone score (TBS), a novel gray-level textural analysis applied to spine DXA images, to estimate indirectly trabecular microarchitecture.
OBJECTIVE: The purpose of this study was to assess TBS from spine DXA images in relation to HRpQCT indices and bone stiffness in radius and tibia in PHPT. DESIGN AND
SETTING: This was a cross-sectional study conducted in a referral center. PATIENTS: Participants were 22 postmenopausal women with PHPT. MAIN OUTCOME MEASURES: Outcomes measured were areal bone mineral density by DXA, TBS indices derived from DXA images, HRpQCT standard measures, and bone stiffness assessed by finite element analysis at distal radius and tibia.
RESULTS: TBS in PHPT was low at 1.24, representing abnormal trabecular microstructure (normal ≥1.35). TBS was correlated with whole bone stiffness and all HRpQCT indices, except for trabecular thickness and trabecular stiffness at the radius. At the tibia, correlations were observed between TBS and volumetric densities, cortical thickness, trabecular bone volume, and whole bone stiffness. TBS correlated with all indices of trabecular microarchitecture, except trabecular thickness, after adjustment for body weight.
CONCLUSION: TBS, a measurement technology readily available by DXA, shows promise in the clinical assessment of trabecular microstructure in PHPT.

Entities:  

Mesh:

Year:  2013        PMID: 23526463      PMCID: PMC3644593          DOI: 10.1210/jc.2012-4255

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score.

Authors:  Sophie Bréban; Karine Briot; Sami Kolta; Simon Paternotte; Mirieme Ghazi; Jacques Fechtenbaum; Christian Roux
Journal:  J Clin Densitom       Date:  2012-03-21       Impact factor: 2.617

2.  The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study.

Authors:  J P Roux; J Wegrzyn; S Boutroy; M L Bouxsein; D Hans; R Chapurlat
Journal:  Osteoporos Int       Date:  2013-03-07       Impact factor: 4.507

3.  The study of hyperparathyroidism at the Massachusetts General Hospital.

Authors:  O Cope
Journal:  N Engl J Med       Date:  1966-05-26       Impact factor: 91.245

4.  Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.

Authors:  M A Krieg; B Aubry-Rozier; D Hans; W D Leslie
Journal:  Osteoporos Int       Date:  2012-10-03       Impact factor: 4.507

5.  Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

6.  "Trabecular Bone Score" (TBS): an indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism.

Authors:  Elisabetta Romagnoli; Cristiana Cipriani; Italo Nofroni; Claudia Castro; Maurizio Angelozzi; Addolorata Scarpiello; Jessica Pepe; Daniele Diacinti; Sara Piemonte; Vincenzo Carnevale; Salvatore Minisola
Journal:  Bone       Date:  2012-12-07       Impact factor: 4.398

7.  Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study.

Authors:  S Boutroy; D Hans; E Sornay-Rendu; N Vilayphiou; R Winzenrieth; R Chapurlat
Journal:  Osteoporos Int       Date:  2012-10-16       Impact factor: 4.507

8.  TBS (trabecular bone score) and diabetes-related fracture risk.

Authors:  William D Leslie; Berengère Aubry-Rozier; Olivier Lamy; Didier Hans
Journal:  J Clin Endocrinol Metab       Date:  2013-01-22       Impact factor: 5.958

9.  Skeletal disease in primary hyperparathyroidism.

Authors:  S J Silverberg; E Shane; L de la Cruz; D W Dempster; F Feldman; D Seldin; T P Jacobs; E S Siris; M Cafferty; M V Parisien
Journal:  J Bone Miner Res       Date:  1989-06       Impact factor: 6.741

10.  Is bone microarchitecture status of the lumbar spine assessed by TBS related to femoral neck fracture? A Spanish case-control study.

Authors:  L M Del Rio; R Winzenrieth; C Cormier; S Di Gregorio
Journal:  Osteoporos Int       Date:  2012-05-12       Impact factor: 4.507

View more
  47 in total

1.  Regional body fat depots differently affect bone microarchitecture in postmenopausal Korean women.

Authors:  J H Kim; H J Choi; E J Ku; A R Hong; K M Kim; S W Kim; N H Cho; C S Shin
Journal:  Osteoporos Int       Date:  2015-10-16       Impact factor: 4.507

Review 2.  Utility of the trabecular bone score (TBS) in secondary osteoporosis.

Authors:  Fabio M Ulivieri; Barbara C Silva; Francesco Sardanelli; Didier Hans; John P Bilezikian; Renata Caudarella
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

3.  Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.

Authors:  Cristiana Cipriani; Federica Biamonte; Aline G Costa; Chiyuan Zhang; Piergianni Biondi; Daniele Diacinti; Jessica Pepe; Sara Piemonte; Alfredo Scillitani; Salvatore Minisola; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2015-02-03       Impact factor: 5.958

4.  Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL): Effects on Bone Structure and Architecture.

Authors:  Catherine M Donlon; Meryl S LeBoff; Sharon H Chou; Nancy R Cook; Trisha Copeland; Julie E Buring; Vadim Bubes; Gregory Kotler; JoAnn E Manson
Journal:  Contemp Clin Trials       Date:  2018-02-23       Impact factor: 2.226

5.  Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.

Authors:  C Senn; B Günther; A W Popp; R Perrelet; D Hans; K Lippuner
Journal:  Osteoporos Int       Date:  2014-04-24       Impact factor: 4.507

Review 6.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

7.  Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.

Authors:  Cristiana Cipriani; Alice Abraham; Barbara C Silva; Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chengchen Zhang; Didier Hans; Shonni J Silverberg; John P Bilezikian
Journal:  Endocrine       Date:  2016-10-18       Impact factor: 3.633

Review 8.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

9.  Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.

Authors:  M D Walker; I Saeed; J A Lee; C Zhang; D Hans; T Lang; S J Silverberg
Journal:  Osteoporos Int       Date:  2016-05-19       Impact factor: 4.507

10.  Trabecular Bone Score in Obese and Nonobese Subjects With Primary Hyperparathyroidism Before and After Parathyroidectomy.

Authors:  Yu-Kwang Donovan Tay; Natalie E Cusano; Mishaela R Rubin; John Williams; Beatriz Omeragic; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.